home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

268 rows where filing_period = "third_quarter", filing_year = 2016 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 268 ✖

filing_year 1

  • 2016 · 268 ✖

filing_period 1

  • third_quarter · 268 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1872353 LOBBYIT.COM 20c97049-8944-485f-8827-56ab700561da Q3 LOBBYIT.COM 400487397 BLADDER CANCER ADVOCACY NETWORK 2016 third_quarter MED Increase awareness of bladder cancer. Advocate in support of H. Res 282 and S. Res. 187, designating May as Bladder Cancer Awareness Month. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2016-09-29T19:27:46.897000-04:00
1872468 NATURAL RESOURCE RESULTS LLC e8ae0c7a-aced-4958-b14a-329e2603a457 Q3 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2016 third_quarter MED Support NNSA grant to client for Molybdenum99 facility; support appropriations language for NNSA grant program to lift cap on grant program. Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2016-10-01T12:37:42.753000-04:00
1872550 MARSHALL BRACHMAN 5af6f769-00f6-4f53-a818-4d4b59059525 Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2016 third_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2016-10-02T10:35:51.677000-04:00
1872636 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) c4fe7b2f-e3ea-4ead-bcba-34d548dfa64c Q3 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2016 third_quarter MED Pharmaceutical labeling Food & Drug Administration (FDA) 18750   0 0 2016-10-03T09:50:00.690000-04:00
1873266 WAKE FOREST UNIVERSITY HEALTH SCIENCES c90358e7-fa59-4619-9d59-83796574070c Q3 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2016 third_quarter MED VA Research Funding; Moonshot Cure Summit 6/29/16, follow -up; Regenerative Medicine Research Funding Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2016-10-05T16:04:57.067000-04:00
1873353 AMERICAN COLLEGE OF CLINICAL PHARMACY 59c67d5f-2758-4630-859e-d3cbbb2897fa Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2016 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   128875 0 0 2016-10-06T10:09:33.290000-04:00
1873575 AMERICAN GASTROENTEROLOGICAL ASSOCIATION a39bf29a-3a3e-492a-b7a1-3413a5f1edee Q3 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 59650 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 2016 third_quarter MED Lobbied in support of funding for digestive disease research at NIH, VA and DoD. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2016-10-06T16:12:30.093000-04:00
1873601 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 98ad3ed9-a90f-42d7-b675-ef726476488a Q3 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 1967 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 2016 third_quarter MED H.R.6-21st Century Cures Act H.R.2646-Helping Families in Mental Health Crisis Act of 2015 H.R.3299-Strengthening Public Health Emergency Response Act H.R.5243-Zika Response Appropriations Act S.1893-Mental Health Awareness and Improvement Act of 2015 S.1945-Mental Health Reform Act of 2015 HOUSE OF REPRESENTATIVES,SENATE   512329 0 0 2016-10-06T22:34:59.390000-04:00
1873930 HOLLAND & KNIGHT LLP bb7dac39-bc4b-4df2-9b44-8663d09e67f2 Q3 HOLLAND & KNIGHT LLP 18466 AMERICAN MEDICAL TECHNOLOGISTS 2016 third_quarter MED Payment and reimbursement for Medicare clinical laboratory testing; Medicare Part B reimbursement policies; Adjustments to Medicare Clinical Laboratory Fee Schedule; Affordable Care Act implementation; Regulation of laboratory-developed tests as medical devices by the Food and Drug Administration; Funding to support harmonization of clinical laboratory test results. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2016-10-07T16:21:47.833000-04:00
1874029 PARRY, ROMANI, DECONCINI & SYMMS 751d77a8-7248-4861-94b7-c512bbaa277e Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2016 third_quarter MED Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2016-10-08T11:39:56-04:00
1874094 O'NEILL AND ASSOCIATES 7369591d-c436-4b08-aa90-92c127ff3052 Q3 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2016 third_quarter MED Medicare advantage and healthcare reform HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2016-10-09T15:07:19.353000-04:00
1874222 FEDERAL SOLUTIONS, LLC 4897468a-0ccf-4981-a2f0-20fca6491b0b Q3 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2016 third_quarter MED Labor/HHS/Education Appropriation Bill: Provisions relating to disease research. Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2016-10-10T12:09:42.717000-04:00
1874240 FEDERAL SOLUTIONS, LLC bd7b7f52-c34b-48e5-bdb7-945a5dea0732 Q3 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2016 third_quarter MED Labor/HHS/Education Appropriations Bill: Provisions relating to disease research, education and development. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2016-10-10T12:13:45.737000-04:00
1874301 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 88a04952-ba19-4065-9259-1aa8fac3f03b Q3 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 3435 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2016 third_quarter MED Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule; H.R.5721 - Local Coverage Determination Clarification Act of 2016 Medicare Clinical Laboratory Fee Schedule; Clinical Laboratory Improvement Amendments of 1988; Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office   60750 0 0 2016-10-10T13:42:25.013000-04:00
1874306 GROUP HEALTH COOPERATIVE e01894b3-f42c-4521-8bcd-96c8771c6d2d Q3 GROUP HEALTH COOPERATIVE 17022 GROUP HEALTH COOPERATIVE 2016 third_quarter MED Health system and medical research topics Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Personnel Management (OPM),SENATE   98000 0 0 2016-10-10T13:44:28.047000-04:00
1874330 CAPITOL CONNECTIONS, LLC c558c83a-0f8c-4de8-bb23-1f67a3149b8f Q3 CAPITOL CONNECTIONS, LLC 303597 KELLEY DRYE & WARREN 2016 third_quarter MED Issues related to NIH research and use of NHPs. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2016-10-10T14:36:50.730000-04:00
1874437 MARSHFIELD CLINIC HEALTH SYSTEM 8088d00f-23b8-4219-82b4-f55cdcfc8534 Q3 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2016 third_quarter MED Protecting Access to Medicare Act of 2014 (PAMA) PAMA includes reforms to the Clinical Lab Fee Schedule (CLFS). This proposed rule for PAMA. MCHS requested a delay in this proposed rule, changes to expand the definition of applicable lab to represent the true market of all laboratories; requested greater transparency of calculations; more time to allow for gathering data and implementation. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   90000 0 0 2016-10-10T16:23:12.330000-04:00
1874623 MR. BRIAN KELLY dd92d12b-7c62-47ba-9fcb-34fd266813e1 Q3 MR. BRIAN KELLY 40024191 INTELLIA THERAPEUTICS 2016 third_quarter MED Gene Editing HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office 15000   0 0 2016-10-11T10:08:03.150000-04:00
1874638 MR. BRIAN KELLY b3042ccb-6dce-4b3b-85f0-3a9d11648ad6 Q3 MR. BRIAN KELLY 40024191 LUNDBECK PHARMACEUTICALS 2016 third_quarter MED FDA Reform HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2016-10-11T10:08:06.227000-04:00
1875022 NELSON MULLINS RILEY & SCARBOROUGH 23fd604f-4c02-40b1-a35d-ae24075c75f0 Q3 NELSON MULLINS RILEY & SCARBOROUGH 285871 NATERA, INC. 2016 third_quarter MED Precision Medicine Initiative, biomedical research, maternal health, TRICARE, Medicaid, and genetic testing HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2016-10-11T15:21:20.397000-04:00
1875025 HOLLAND & KNIGHT LLP cc96cfb9-b0e7-42e5-81e3-1d2c584170c5 Q3 HOLLAND & KNIGHT LLP 18466 THE BIOSIMILARS FORUM 2016 third_quarter MED Medicare reimbursement issues, FDA regulation of biosimilars. HOUSE OF REPRESENTATIVES,SENATE 120000   0 0 2016-10-11T15:25:21.837000-04:00
1875034 ALZHEIMER'S FOUNDATION OF AMERICA d92d1493-2d1c-482e-bc47-ad822ec7a536 Q3 ALZHEIMER'S FOUNDATION OF AMERICA 323158 ALZHEIMER'S FOUNDATION OF AMERICA 2016 third_quarter MED H.R. 6- 21st Century Cures initiative S. 2067,the Ensuring Useful Research Expenditures is Key for Alzheimers (EUREKA) Act Senate HELP Committee companion to 21st Century Cures H.R. 5366 - the Alzheimers Breakthrough Sunshine Act Administration on Aging,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   28000 0 0 2016-10-11T15:35:27.543000-04:00
1875093 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 63d6f17a-a148-48bf-a2d6-236a1bbcef43 Q3 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 48975 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 2016 third_quarter MED Support HR 3285 Oppose HR 2646 Agriculture, Dept of (USDA),Bureau of Alcohol Tobacco Firearms & Explosives,Bureau of Prisons (BOP),Bureau of the Census,Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Council of Economic Advisers (CEA),Defense, Dept of (DOD),Education, Dept of,Election Assistance Commission (EAC),Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Federal Communications Commission (FCC),Federal Deposit Insurance Corporation (FDIC),Federal Housing Finance Agency (FHFA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Interior, Dept of (DOI),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Credit Union Administration (NCUA),Natl Institute of Standards & Technology (NIST),Natl Telecommunications & Information Administration (NTIA),Office of Faith-Based & Community Initiatives,Office of Management & Budget (OMB),Office of the Comptroller of the Currency (OCC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office   68750 0 0 2016-10-11T16:45:29.953000-04:00
1875133 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 15642798-2bdd-47a5-a7c3-e608244bcd59 Q3 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1672 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 2016 third_quarter MED Lobbing to House and Senate Appropriations committee chairs and ranking members about NIDCR funding HOUSE OF REPRESENTATIVES,SENATE   19929 0 0 2016-10-11T16:49:31.737000-04:00
1875197 CONNECT 4 STRATEGIES, LLC 054e7b32-5fbc-4ca1-a488-df6f42250254 Q3 CONNECT 4 STRATEGIES, LLC 401103720 THERABRON THERAPEUTICS, INC 2016 third_quarter MED HR1573 & S1878 Pediatric Pediatric Priority Review Voucher Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2016-10-11T20:41:26.763000-04:00
1875550 ARNALL GOLDEN GREGORY, LLP cbc0dff1-e931-4125-a78f-e2f7cc7ed9f2 Q3 ARNALL GOLDEN GREGORY, LLP 400713137 PHARMA AND BIOPHARMA OUTSOURCING ASSOCIATION 2016 third_quarter MED FDA oversight issues of generic drugs; issues regarding generic drug user fees; 21st Century CURES Act; Innovation for Healthier Americans Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2016-10-12T14:00:01.390000-04:00
1876129 PARALYZED VETERANS OF AMERICA c5b44359-53ae-4263-8f95-e3c5c8e896fd Q3 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2016 third_quarter MED S. 800, the Enhancing the Stature and Visibility of Medical Rehabilitation Research at the National Institutes of Health Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE   69613 0 0 2016-10-13T08:56:40.207000-04:00
1876134 AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES 29cc556f-98a2-457e-b398-00f3ff4c319c 3A AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES 1524 AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO 2016 third_quarter MED Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components" HOUSE OF REPRESENTATIVES,SENATE     0 0 2016-10-13T09:04:44.030000-04:00
1876398 ACT FOR NIH 8cc4ccf7-ac28-43a6-b7b1-8670e311512c Q3 ACT FOR NIH 401103441 ACT FOR NIH 2016 third_quarter MED Advancing biomedical research; immediate restoration of funding for NIH HOUSE OF REPRESENTATIVES,SENATE   140000 0 0 2016-10-13T11:02:01.040000-04:00
1876511 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) e60274a1-8421-49d3-a0e7-c8d6f8d7c9e4 Q3 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2016 third_quarter MED AACC contacted Senate HELP leaders to urge that the CLIA amendments be modernized to address concerns regarding oversight of laboratory developed tests rather than expanding Food and Drug Administration oversight of the tests. HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2016-10-13T11:46:26.660000-04:00
1876513 TCH GROUP, LLC a5d9829f-a6cc-4484-9531-e4a38a73b3e1 Q3 TCH GROUP, LLC 51478 INTERNATIONAL AIDS VACCINE INITIATIVE 2016 third_quarter MED The House (HR 5912) and Senate (S 3117) FY 17 State Foreign Operations Appropriations bill, and the Continuing Resolution (HR 5325). Specifically, Federal funding for AIDS vaccine research and development. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2016-10-13T11:47:29.053000-04:00
1876577 FAEGRE DRINKER BIDDLE & REATH LLP 81996310-4130-415e-89ae-2c158b46b426 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2016 third_quarter MED Issues related to priority review voucher for tropical diseases. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) 10000   0 0 2016-10-13T12:45:22.377000-04:00
1876587 FAEGRE DRINKER BIDDLE & REATH LLP 8e25f4bf-d2b2-4014-b725-eeccc71deefb Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 NANOMEDICINES ALLIANCE 2016 third_quarter MED Research and development related to nanomedicine       0 0 2016-10-13T12:54:30.170000-04:00
1876588 FAEGRE DRINKER BIDDLE & REATH LLP b9970046-fe24-4190-831b-ff50368c815d Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2016 third_quarter MED Public Health Programs for Infectious and Tropical Disease; NIH Research; Issues related to government agency conference travel. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,U.S. Agency for International Development (USAID) 30000   0 0 2016-10-13T12:58:31.393000-04:00
1876610 MARIJUANA POLICY PROJECT e582a0fe-cb05-441b-bc92-bce8e8ce48fc Q3 MARIJUANA POLICY PROJECT 74330 MARIJUANA POLICY PROJECT 2016 third_quarter MED Lobbied House and Senate lawmakers for the removal of onerous, duplicative, and unnecessary barriers to research into potential medical applications of marijuana. HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2016-10-13T13:13:43.867000-04:00
1876721 FAEGRE DRINKER BIDDLE & REATH LLP b9bd679a-5149-4ac9-8be4-b1d191dfa3d6 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 ALLIANCE FOR BIOSECURITY 2016 third_quarter MED BioShield Project; Biomedical Countermeasures; Biodefense Research and Development Authority; Pandemic and All-Hazards Preparedness Reauthorization (H.R. 2405 and the Public Law); H.R. 1300, the First Responder Anthrax Preparedness Act; S.2055, Medical Countermeasure Innovations Act of 2015 provision regarding priority review vouchers contracting; Companion bill to H.R. 6, 21st Century Cures Act; extended immunity from tort liability for claims of loss caused by countermeasures against diseases or other threats of public health emergencies under the Public Readiness and Emergency Preparedness Act of 2005 Pub.L.No. 109-417 (120STAT.2831); H.R. 3299, Strengthening Public Health Emergency Response Act of 2015, provisions regarding priority review vouchers contracting; S.1915 First Responder Anthrax Preparedness Act; H.R. 2577, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act of 2017, provisions relating to the Zika supplemental bill. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2016-10-13T14:00:59.910000-04:00
1876876 HACKENSACK MERIDIAN HEALTH bdca270d-4e04-464f-81f1-6866af232406 Q3 HACKENSACK MERIDIAN HEALTH 401104109 HACKENSACK MERIDIAN HEALTH 2016 third_quarter MED National Institutes of Health appropriations 340B designation and funding Behavioral health funding 21st Century Cures Substance abuse, opioids, and patient data Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   25000 0 0 2016-10-13T15:39:56.777000-04:00
1877617 GRIZZLE COMPANY c465a15c-09bf-46a3-99b9-9512304e8090 Q3 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2016 third_quarter MED HR 5549 The Medical Marijuana Research Act. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2016-10-14T13:01:20.140000-04:00
1877625 RAY C CULVER III 6e410325-6675-41bd-bcd3-74afabc721c2 Q3 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2016 third_quarter MED Funding for USDA Agricultural Research Service human nutrition research centers in the FY2017 Agricultural Appropriations/Continuing Resolution/Omnibus bills. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2016-10-14T13:04:23.833000-04:00
1877724 FAEGRE BAKER DANIELS CONSULTING a363ba9b-d5e4-4095-97c4-bdea951394de Q3 FAEGRE BAKER DANIELS CONSULTING 34158 MYRIAD GENETIC LABORATORIES, INC. 2016 third_quarter MED FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2016-10-14T14:27:49.813000-04:00
1877734 VAN FLEET ASSOCIATES b6bee92f-22cd-4369-a580-bd32980c6624 Q3 VAN FLEET ASSOCIATES 39781 BELLUS MEDICAL 2016 third_quarter MED Gain approval of specific medical technologies (microneedling) regulated by the Federal Food and Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2016-10-14T14:36:58.953000-04:00
1877805 THE PETRIZZO GROUP, INC. c95428fa-419e-44b7-8a54-0c5351d0caff Q3 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2016 third_quarter MED Advocated for funding of NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative. Advocated for improvements to FDA approval process. Advocated in favor of standardized electronic medical records. HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2016-10-14T15:04:38.207000-04:00
1877809 THE PETRIZZO GROUP, INC. f24572ab-6c64-4db9-adc3-5d8f41fe912e Q3 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2016 third_quarter MED Advocated for funding of the BRAIN Initiative and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2016-10-14T15:05:42.160000-04:00
1877813 THE PETRIZZO GROUP, INC. c17a2b0d-5408-49d5-9e0d-1240cf3c9ca7 Q3 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2016 third_quarter MED Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery. Advocated for improvements to FDA approval process. HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2016-10-14T15:06:46.303000-04:00
1877895 LNE GROUP 4a6bd879-dcf9-4034-afeb-923389534579 Q3 LNE GROUP 308811 PARKER HANNIFIN 2016 third_quarter MED Lobbied for Issues Related to Medical/Disease Research/ Clinical Labs HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2016-10-14T15:18:27.990000-04:00
1878044 PERSONALIZED MEDICINE COALITION 48fc002b-e11a-4892-bb05-5c660062154a Q3 PERSONALIZED MEDICINE COALITION 40046362 PERSONALIZED MEDICINE COALITION 2016 third_quarter MED Personalized medicine regulation, CMS coverage of personalized medicines and diagnostics & PAMA implementation, CER and Genomics, FDA regulation of personalized medicine, regulation of laboratory developed tests, 21st Century Cures Initiative, Healthier Americans Initiative, Precision Medicine Initiative and Cancer Moonshot task-force, medical device and prescription drug user-fees Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2016-10-14T16:28:01.517000-04:00
1878270 THE CJR GROUP, INC. 8ee5b21d-f13e-4fb4-b25a-281bfd6e5f0d Q3 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2016 third_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2016-10-15T11:13:11.117000-04:00
1878384 FRANCIS EDWARD & CRONIN, INC. fac643c7-e329-401b-8035-6d332e6700bd Q3 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2016 third_quarter MED issues and legislation related to Alzheimer's disease research. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office 10000   0 0 2016-10-16T17:12:21.363000-04:00
1878476 SRI INTERNATIONAL 6231e146-bc9d-440f-858b-d03f66101654 Q3 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2016 third_quarter MED FY17 Labor/HHS/Education Appropriations (House and Senate) 21st Century Cures Act HOUSE OF REPRESENTATIVES,SENATE   8000 0 0 2016-10-17T08:51:12.230000-04:00
1878482 WILLIAMS AND JENSEN, PLLC f7d70230-2f3a-45ff-aa59-5c8722ce64c9 Q3 WILLIAMS AND JENSEN, PLLC 41454 BIOGEN IDEC 2016 third_quarter MED 21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); medical research at NIH. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2016-10-17T08:51:13.653000-04:00
1878486 WILLIAMS AND JENSEN, PLLC 3b94d7cb-d8a3-4720-be03-a04063cc0749 Q3 WILLIAMS AND JENSEN, PLLC 41454 VERTEX PHARMACEUTICALS INCORPORATED 2016 third_quarter MED 21st Century Cures Initiative H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine. S. 2030 Advancing Targeted Therapies for Rare Diseases Act of 2015. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2016-10-17T08:52:14.793000-04:00
1878622 AMERICAN ASSOCIATION FOR DENTAL, ORAL, AND CRANIOFACIAL RESEARCH 0a7354b2-573c-479c-8b73-03a673cbabfd Q3 AMERICAN ASSOCIATION FOR DENTAL, ORAL, AND CRANIOFACIAL RESEARCH 40049382 AMERICAN ASSOCIATION FOR DENTAL, ORAL, AND CRANIOFACIAL RESEARCH 2016 third_quarter MED Accelerating Biomedical Research Act (S. 318/H.R. 531), 21st Century Cures Act (H.R. 6), Senate HELP Committee Innovation for Healthier Americans initiative and other legislative proposals pertinent to NIH policy. HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2016-10-17T09:58:34.137000-04:00
1879228 FAEGRE DRINKER BIDDLE & REATH LLP 5c5f209e-5c3c-48af-b65a-9951aaae65cb Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREECLAMPSIA FOUNDATION 2016 third_quarter MED Preeclampsia Research Issues; maternal mortality. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH) 10000   0 0 2016-10-17T13:13:38.437000-04:00
1879394 AMERICAN ASSOCIATION FOR CANCER RESEARCH d3f494c1-cd1d-4397-8d91-9920df2ef519 Q3 AMERICAN ASSOCIATION FOR CANCER RESEARCH 400601833 AMERICAN ASSOCIATION FOR CANCER RESEARCH 2016 third_quarter MED H.R. 6, 21st Century Cures Act Senate Innovation Initiative Laboratory-developed tests HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2016-10-17T13:46:04.713000-04:00
1879672 AMERICAN CLINICAL LABORATORY ASSN 52c11390-1aee-4898-85c8-34ad27f6a9c5 Q3 AMERICAN CLINICAL LABORATORY ASSN 1923 AMERICAN CLINICAL LABORATORY ASSN 2016 third_quarter MED Reimbursement and coverage issues related to the Medicare Clinical Laboratory Fee Schedule and the Physician Fee Schedule, including implementation of the Protecting Access to Medicare Act (P.L. 113-93) and cost-sharing for clinical laboratory services under Part B; H.R. 6, 21st Century Cures Act; the regulation and oversight of clinical laboratories, including laboratory-developed tests; narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; H.R. 2, the Medicare Access and CHIP Reauthorization of 2015; and H.R 4909, the National Defense Authorization Act for Fiscal Year 2017. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   199612 0 0 2016-10-17T14:37:32.477000-04:00
1880003 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 882c94d5-5fb0-4d5c-9cb8-9e38c9b189bf Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN BRAIN TUMOR ASSOCIATION 2016 third_quarter MED FY 17 Defense Appropriations Act, cancer research, HR 5293/S.3000 FY 17 Labor-HHS-Education Appropriations Act, S. 3040/ H.R. 5926, NIH, Cancer Research S. 2943, National Defense Authorization Act, funding for Department of Defense Medical research. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2016-10-17T15:39:58.033000-04:00
1880079 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. dd10007c-b2dd-4770-81da-1b8e8144e379 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2016 third_quarter MED S.3040; H.R. 5926, FY 2017, Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention. HR 5293/ S. 3000, FY 2017, Defense Appropriations, FY 2017 defense health programs, Tuberous Sclerosis Complex Research Program. S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical Research. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2016-10-17T15:53:52.670000-04:00
1880089 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bf22fccc-0f3a-4530-9ba4-555064a2e89e Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION 2016 third_quarter MED Research opportunities at the Department of Defense and the Centers for Disease Control. S. 3040/ H.R. 5926, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders H.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs H.R. 1849, HHT Diagnosis and Treatment Act S. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2016-10-17T15:56:00.220000-04:00
1880359 MCDERMOTT+ LLC a1c662cf-e2a8-4ab8-80e9-17718dfbdc0b Q3 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2016 third_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2016-10-17T16:40:32.150000-04:00
1880601 CARDINAL HEALTH, INC. 013a7fe5-4099-4249-adcf-4b50282d2e1d Q3 CARDINAL HEALTH, INC. 58055 CARDINAL HEALTH INC 2016 third_quarter MED H.R. 6: 21st Century Cures Act (entire bill) Medical Device Tax HOUSE OF REPRESENTATIVES,SENATE   340000 0 0 2016-10-17T17:52:29.260000-04:00
1880878 THORN RUN PARTNERS 2ed59c81-f722-43ec-9471-9ce976ba5550 Q3 THORN RUN PARTNERS 400534596 CONTINUING MEDICAL EDUCATION COALITION 2016 third_quarter MED H.R.293/S.2978, Protect Continuing Physician Education and Patient Care Act. H.R.6, 21st Century Cures Act. S.2153, Provider Payment Sunshine Act. Issues related to the promotion of continuing medical education and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2016-10-18T09:34:19.963000-04:00
1880894 THORN RUN PARTNERS 019f3d44-5e52-4071-9e73-d1c6a8b1df03 Q3 THORN RUN PARTNERS 400534596 NOVARTIS CORPORATION 2016 third_quarter MED Issues related to biologics. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2016-10-18T09:40:31.733000-04:00
1880943 THORN RUN PARTNERS a2b06e5c-6057-4ea4-b42f-cdd07728c3e5 Q3 THORN RUN PARTNERS 400534596 CHILDRENS HOSPITAL COLORADO 2016 third_quarter MED Issues related to pediatric research and childrens hospital graduate medical education. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2016-10-18T09:53:57.760000-04:00
1880945 THORN RUN PARTNERS c711567c-8ef3-49d3-bbc8-61ca26c59c0d Q3 THORN RUN PARTNERS 400534596 ABBVIE INC. 2016 third_quarter MED Issues related to National Institutes of Health (NIH), Centers for Disease Control (CDC), and other funding. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2016-10-18T09:56:00.107000-04:00
1880974 THORN RUN PARTNERS 61ea358d-9cba-44e8-aa1b-d33a59a1bffe Q3 THORN RUN PARTNERS 400534596 ABBOTT LABORATORIES 2016 third_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2016-10-18T09:58:07.030000-04:00
1881163 NORTHWESTERN UNIV 4371ab87-4586-4ab9-83ab-5b9d9a423265 Q3 NORTHWESTERN UNIV 299992 NORTHWESTERN UNIV 2016 third_quarter MED S. 289/H.R. 2104 American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. H.R. 6, 21st Century Cures Act, Title I and II. H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill. S. 2713, Advancing Precision Medicine Act of 2016, entire bill. HOUSE OF REPRESENTATIVES,SENATE   176233 0 0 2016-10-18T10:33:16.607000-04:00
1881194 CORNERSTONE GOVERNMENT AFFAIRS, INC. 772c5758-6868-46ef-9c1b-4b40a411f43c Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CITY OF HOPE MEDICAL CENTER 2016 third_quarter MED Medicare/Medicaid reimbursement, clinical research HOUSE OF REPRESENTATIVES 30000   0 0 2016-10-18T10:36:35.970000-04:00
1881247 NESTLE USA 7aab7c8c-9d0c-4604-8bc2-6104af9086f4 Q3 NESTLE USA 29037 NESTLE USA 2016 third_quarter MED Medical Foods Equity Act. S. 2736/H.R. 5210 Patient Access to Durable Medical Equipment Act. Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Pension Benefit Guaranty Corporation (PBGC),SENATE,Treasury, Dept of   440000 0 0 2016-10-18T10:45:05.103000-04:00
1881421 NORTHWESTERN UNIV ff2d70ff-9d4c-4d75-9d0e-27edaf2f8909 3A NORTHWESTERN UNIV 299992 NORTHWESTERN UNIV 2016 third_quarter MED S. 289/H.R. 2104 American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. H.R. 6, 21st Century Cures Act, Title I and II. H.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill. S. 2713, Advancing Precision Medicine Act of 2016, entire bill. HOUSE OF REPRESENTATIVES,SENATE   177513 0 0 2016-10-18T11:10:32.017000-04:00
1881583 TODD STRATEGY GROUP 60d4dab7-92f7-45d0-b85f-a7ba0504cb50 Q3 TODD STRATEGY GROUP 401103321 BIODESIX, INC. 2016 third_quarter MED FDA regulation of laboratory developed tests. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2016-10-18T11:33:05.723000-04:00
1881601 THORN RUN PARTNERS ec438e5b-6806-47a1-9668-6e5a1546d482 Q3 THORN RUN PARTNERS 400534596 HACKENSACK MERIDIAN HEALTH 2016 third_quarter MED Issues relating to research funding, NIH and other matters. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2016-10-18T11:34:15.413000-04:00
1881615 TODD STRATEGY GROUP c5be9cd1-4745-4b41-9a14-6a215bcd6178 Q3 TODD STRATEGY GROUP 401103321 MYRIAD GENETIC LABORATORIES INC 2016 third_quarter MED FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced). Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2016-10-18T11:36:22.650000-04:00
1881640 TODD STRATEGY GROUP 5d27655b-4674-445b-b36b-77a2328ee879 Q3 TODD STRATEGY GROUP 401103321 VERACYTE, INC. 2016 third_quarter MED FDA regulation of laboratory developed tests. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2016-10-18T11:38:34.277000-04:00
1881779 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 696053bc-7a1e-4f21-a1e0-3ba223e3d2e4 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ENDOCRINE SOCIETY 2016 third_quarter MED Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill, S. 2745; HR 2101 Research for All act of 2015; inclusion in research; S. 1101 MEDTECH Act Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2016-10-18T12:00:50.233000-04:00
1881785 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 154908f0-94cb-44a4-bd02-fd0ded9da77b Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2016 third_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2016-10-18T12:01:55.530000-04:00
1881805 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9c27e79a-87d3-4515-979a-70a1cadee1a7 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2016 third_quarter MED Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease. HR 1807, Sickle Cell Disease Research Surveillance Prevention and Treatment Act of 2015; Resolution on Sickle Cell Disease Trait Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2016-10-18T12:05:03.580000-04:00
1881827 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 702e2f60-a412-4860-958c-6ad7f97e03c3 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2016 third_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 50000   0 0 2016-10-18T12:06:14.973000-04:00
1881921 LOCKRIDGE, GRINDAL, NAUEN, PLLP 06e798e2-fdbb-432b-a727-db865163d80d Q3 LOCKRIDGE, GRINDAL, NAUEN, PLLP 23053 HENNEPIN COUNTY MEDICAL CENTER 2016 third_quarter MED FY2017 Authorizations, Appropriations, and Budget Policy HOUSE OF REPRESENTATIVES,SENATE     0 0 2016-10-18T12:22:13.097000-04:00
1882078 STANFORD UNIVERSITY c8ad2c35-72ae-49ba-bfe8-30c8efcd4d54 Q3 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2016 third_quarter MED Health Professions Programs Graduate Medical Education Funding S1148; HR2124 Resident Physician Shortage Reduction Act of 2015 Precision Medicine Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE   60000 0 0 2016-10-18T12:52:49.283000-04:00
1882571 INTUITIVE SURGICAL, INC. cc520144-690f-49b1-a02c-c45354b23047 Q3 INTUITIVE SURGICAL, INC. 400670004 INTUITIVE SURGICAL, INC. 2016 third_quarter MED comparative effectiveness research in healthcare; medical research issues Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2016-10-18T14:03:29.447000-04:00
1882794 SQUIRE PATTON BOGGS 8c314fee-446e-4478-a231-c97bcabbdd81 Q3 SQUIRE PATTON BOGGS 30906 UNIVERSITY OF GEORGIA 2016 third_quarter MED Traumatic brain injury research, funding, and outreach opportunities. Zika research funding. Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID) 40000   0 0 2016-10-18T14:34:02.100000-04:00
1883599 ISEMAN & ASSOCIATES LLC 01cb01c1-3cb9-40a8-8126-67c0c6e7b8e7 Q3 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2016 third_quarter MED Monitoring biotech legislation HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2016-10-18T16:17:17.613000-04:00
1883775 WEBMD HEALTH CORP. 001f49b8-6b41-4749-8121-45939c1f5467 Q3 WEBMD HEALTH CORP. 55473 WEBMD HEALTH CORP 2016 third_quarter MED Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records. S.2978 (Barrasso R-WY) --- A Bill to amend title XI of the Social Security Act to exempt certain transfers for educational purposes from manufacturer transparency reporting requirements). SENATE   10000 0 0 2016-10-18T16:54:04.333000-04:00
1884726 VAN SCOYOC ASSOCIATES e13a43de-aa82-45ae-892a-164ea4acfe77 Q3 VAN SCOYOC ASSOCIATES 39837 AMERICAN CLINICAL LABORATORY ASSOCIATION 2016 third_quarter MED No lobbying activity. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2016-10-19T07:44:47.813000-04:00
1884824 RAMPY NORTHRUP LLC f94a2f30-034b-442a-b17d-c8ba94dce0e1 Q3 RAMPY NORTHRUP LLC 401103289 AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA) 2016 third_quarter MED Implementation of P.L.113-93, Protecting Access to Medicare Act of 2014 (changes to reimbursement for clinical laboratory services). Proposals concerning the Stark Law's in-office ancillary services exception. Policies impacting Medicare reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. H.R.6, 21st Century Cures Act. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2016-10-19T08:57:37.317000-04:00
1884962 CAPITOL HILL STRATEGIES, LLC db4b4e3d-c0f4-4f7b-9806-25f8bfeb868c Q3 CAPITOL HILL STRATEGIES, LLC 91774 PHRMA 2016 third_quarter MED S. 320, The Medical Innovation Act. Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research. H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) Senate Innovations for Healthy Americans Act (text not yet available but likely multiple provisions similar to H.R. 6 including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) S. 1878, Advancing Hope Act of 2015 legislation that amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2016-10-19T09:38:03.147000-04:00
1885006 CAPITOL HILL STRATEGIES, LLC 6b59ee56-53d2-4601-9d15-2c144303e3fb Q3 CAPITOL HILL STRATEGIES, LLC 91774 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2016 third_quarter MED H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) S. 320, The Medical Innovation Act. Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research. Senate Innovations for Healthy Americans Act (text not yet available but likely multiple provisions similar to H.R. 6 including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) S. 1878, Advancing Hope Act of 2015 legislation that amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2016-10-19T09:57:31.963000-04:00
1885102 VAN SCOYOC ASSOCIATES f120538d-76c8-4546-ba79-e4bc164e89ce Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF NOTRE DAME 2016 third_quarter MED Zika virus research and development related issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2016-10-19T10:07:22.127000-04:00
1885122 CAPITOL HILL STRATEGIES, LLC 47f335c5-ea63-480c-814a-f94ade459458 Q3 CAPITOL HILL STRATEGIES, LLC 91774 BIOGEN INC 2016 third_quarter MED H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets) Issues dealing with newborn screening. S. 1878, Advancing Hope Act of 2015 legislation that amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2016-10-19T10:09:36.503000-04:00
1885444 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8e857456-c107-4ecb-936e-74667a040eaa Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2016 third_quarter MED Precision Medicine Initiative Regulation of laboratory diagnostics Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office 60000   0 0 2016-10-19T10:45:00.457000-04:00
1885452 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 560b662e-2d5f-4005-a6d8-d5cd8b8d6e6f Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 COUNSYL 2016 third_quarter MED Regulation and oversight of diagnostics Cancer Moonshot Reimbursement of diagnostics Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 30000   0 0 2016-10-19T10:46:08.817000-04:00
1885471 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c35028f8-202a-43dd-aca6-a262b3784326 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY 2016 third_quarter MED Next generation sequencing based diagnostics Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2016-10-19T10:48:19.287000-04:00
1885557 HOLLAND & KNIGHT LLP d6b00a05-ecab-45ac-b4f5-937f07cf137d Q3 HOLLAND & KNIGHT LLP 18466 PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION 2016 third_quarter MED Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; the FY 2017 Ag-FDA Appropriations bill (S.1800 & H.R. 5054); Implementation of the White House Cancer Moonshot Task Force. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,White House Office 90000   0 0 2016-10-19T10:55:16.733000-04:00
1885607 UNIVERSITY OF ROCHESTER 946e88bf-3b49-4a23-8c56-057c61a704d2 Q3 UNIVERSITY OF ROCHESTER 301937 UNIVERSITY OF ROCHESTER 2016 third_quarter MED S. 289, America Cures Act H.R. 6, 21st Century Cures Act S. 2742, Promoting Biomedical Research and Public Health for Patients Act HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2016-10-19T10:58:45.237000-04:00
1885713 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5c496afc-5254-453b-a074-e4ba3ea9e82d Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 CURE FORWARD 2016 third_quarter MED Precision Medicine Initiative Cancer Moonshot Patient Access to lab Results Regulation of Health Software HR 6 21st Century Cures S. 1101 MEDTECH Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2016-10-19T11:07:34.023000-04:00
1885728 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 1bbf3d81-1ec4-4d84-89cf-41009f0d0bac Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 23ANDME, INC. 2016 third_quarter MED Direct to consumer genetic testing Regulation and oversight of diagnostics Precision Medicine Initiative S.2744, Genetic Research Privacy Protection Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 20000   0 0 2016-10-19T11:08:44.963000-04:00
1885758 CURATORS OF THE UNIVERSITY OF MISSOURI eec4ea21-cebe-40dc-946a-d0dbe9c2d0d7 Q3 CURATORS OF THE UNIVERSITY OF MISSOURI 43616 CURATORS OF THE UNIVERSITY OF MISSOURI 2016 third_quarter MED 21st Century Cures Act, all issues relating to the National Institutes of Health (NIH) and the NIH Innovation Fund. S. 2742 Promoting Biomedical Research and Public Health for Patients Act, all issues S. 2700 National Institutes of Health (NIH) Workforce Authorities Modernization Act, all issues S. 2713 Advancing Precision Medicine Act of 2016, all issues S. 2745 Advancing NIH Strategic Planning and Representation in Medical Research Act, all issues S. 2742 Promoting Biomedical Research and Public Health for Patients Act, all issues HR5395, S.2873 ECHO Act, all issues. H.R. 2713/S. 3245 Title VIII Nursing Workforce Reauthorization Act of 2015, all issues Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2016-10-19T11:13:05.827000-04:00
1886015 FORBES-TATE ba61897c-d751-4914-a5a5-2a9ebff6904e Q3 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2016 third_quarter MED Issues related to Medicare and Medicaid payments to physicians; issues related to medical imaging; issues related to Sustained Growth Rate (SGR); issues related to medical imaging within the VA system. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2016-10-19T11:37:26.177000-04:00
1886087 UNIVERSITY OF IOWA 81b2f2a6-4529-46b9-b907-5f216f6d8bfb Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2016 third_quarter MED Residency Caps Minority Improvement NIOSH Education and Research Centers for Occupational Health and Safety FY 16 Appropriations FY 17 Appropriations Prevention Research Centers Resident Physician Shortage Health Care Reform 21st Century Cures Act NIH chimera research guidelines Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   86662 0 0 2016-10-19T11:40:55.943000-04:00
1886186 THE PAUL LAXALT GROUP 0975ee42-2378-4007-8ed0-2a8c04bfb791 Q3 THE PAUL LAXALT GROUP 22325 THE ROGOSIN INSTITUTE 2016 third_quarter MED The Chronic Kidney Disease Improvement in Research and Treatment Act S.598 H.R.1130. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2016-10-19T11:51:37.017000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 3412.541ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API